Roberts David B's Form 4 filing
Lemaitre Vascular Inc (LMAT) · filed Mar 13, 2026
- Accession no.
- 0001193125-26-106293
- Filed
- Mar 13, 2026
- Trade date
- Mar 11, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market sales total $356.6K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Roberts David BCIK 0001365731 | Director, Officer (President and Director) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 11, 2026 | Common Stock | SSaleDisposed | −3,311.68 | $107.68F1 | −$356,601.7 | 14,667.32 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $106.52 to $108.65. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.